Anesthesia progress最新文献

筛选
英文 中文
Dental Treatment Under General Anesthesia With Nasal Intubation in a Patient With Selective Immunoglobulin A Deficiency. 选择性免疫球蛋白a缺乏症患者在全麻下鼻插管的牙科治疗。
Anesthesia progress Pub Date : 2023-09-01 DOI: 10.2344/anpr-70-02-13
Yuho Sakuma, Mika Ogawa, Chie Nakagawa, Kodai Momota, Emi Kaji, Kingo Matsumura, Saori Morinaga, Kentaro Nogami, Mizuko Ikeda
{"title":"Dental Treatment Under General Anesthesia With Nasal Intubation in a Patient With Selective Immunoglobulin A Deficiency.","authors":"Yuho Sakuma, Mika Ogawa, Chie Nakagawa, Kodai Momota, Emi Kaji, Kingo Matsumura, Saori Morinaga, Kentaro Nogami, Mizuko Ikeda","doi":"10.2344/anpr-70-02-13","DOIUrl":"10.2344/anpr-70-02-13","url":null,"abstract":"<p><p>Immunoglobulin A (IgA) deficiency is one of the most common immune disorders characterized by increased susceptibility to infections, especially involving the respiratory tract and mucosal surfaces of the mouth, gingiva, and nasal sinus. Because dental surgery and general anesthesia may pose an increased risk for systemic infections, management of IgA-deficient patients requires caution during dental procedures and intubated general anesthesia. We report a 5-year-old female patient with IgA deficiency who underwent extraction of 18 deciduous teeth under general anesthesia. Antibiotic prophylaxis and antiseptic mouthwash were used perioperatively to reduce bacteremia risks. Nasotracheal intubation was carefully performed after applying topical disinfectants and epinephrine-containing gauze packing into the nasal cavity to minimize trauma. The patient was carefully monitored overnight in the hospital and discharged without any signs or symptoms of infection the next day. Dental anesthesia providers must be aware of the potential implications for safe practice when managing patients with IgA deficiency.</p>","PeriodicalId":94296,"journal":{"name":"Anesthesia progress","volume":"70 3","pages":"140-141"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11080969/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41242875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review of Current Literature of Interest to the Office-Based Anesthesiologist. 办公室麻醉师感兴趣的当前文献综述。
Anesthesia progress Pub Date : 2023-09-01 DOI: 10.2344/anpr-70-03-154
Mark A Saxen
{"title":"A Review of Current Literature of Interest to the Office-Based Anesthesiologist.","authors":"Mark A Saxen","doi":"10.2344/anpr-70-03-154","DOIUrl":"10.2344/anpr-70-03-154","url":null,"abstract":"When muscle relaxants are used to facilitate intubation, a significant amount of residual neuromuscular blockade remains when reversal drugs are not administered; however, routine reversal is not a universal practice. While most anesthesiologists routinely reverse neuromuscular blockade if muscular weakness is suspected at the time of extubation, others caution against the routine use of anticholinesterase reversal agents, which have been associated with impaired upper airway and breathing function with increased risk of adverse postoperative respiratory events. Neostigmine has neuromuscular blocking properties when given in the absence of neuromuscular blockade and can induce paradoxical reduction in the train-of-four ratio (TOF ratio). This study tested the hypothesis that TOF ratios in patients receiving neostigmine at the time of postanesthesia care unit admission would not be less than TOF ratios in patients randomly assigned to receive a saline placebo. The authors also tested the hypothesis that the incidence of postextubation adverse respiratory symptoms and muscle weakness would not be increased in the neostigmine group. One hundred twenty patients undergoing general anesthesia received a small dose of rocuronium to facilitate intubation. Ninety patients achieved a TOF ratio of 0.9 to 1.0 and received either neostigmine or saline. Patients were subsequently monitored for muscle strength and postextubation respiratory adverse events. No significant difference in these parameters was noted between the 2 groups, leading the authors to conclude that administration of neostigmine at neuromuscular recovery was not associated with clinical evidence of anticholinesterase-induced muscle weakness. Comment: This study is accompanied by an editorial (Brull SJ, Naguib M. How to catch unicorns (and other fairytales). Anesthesiology. 2018;128:1–3) that discusses long-standing beliefs and misconceptions about the relative risk and benefits of administering muscle relaxants. The editors praise the study by Murphy et al for debunking 4 common myths. First, the study shows no evidence that neostigmine, at a dose of 40 lg/ kg, induces signs or symptoms of neuromuscular weakness, contradicting previous reports. Second, it challenges the belief that clinical assessment alone (eg, 5second head lift) is sufficient to assess adequate muscle recovery and underscores the need for quantitative neuromuscular assessment (TOF ratio). The study also challenged the widely held belief that neuromuscular recovery can be subjectively assessed by watching or feeling the response to TOF stimulation. Finally, the ‘‘time elapsed’’ principle of reversal is debunked. This principle stated that reversal was not necessary if the duration since the last dose of neuromuscular blocking agent was greater than 1 or 2 elimination half-lives, noting that 21% of patients failed to recover to a TOF ratio of 0.9 in 163 minutes after a single dose of 0.3 mg/ kg rocuronium. The editorial prov","PeriodicalId":94296,"journal":{"name":"Anesthesia progress","volume":"70 3","pages":"154-155"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41242874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medication Safety: Reducing Anesthesia Medication Errors and Adverse Drug Events in Dentistry Part 1. 用药安全:减少牙科麻醉用药错误和药物不良事件第1部分。
Anesthesia progress Pub Date : 2019-01-01 DOI: 10.2344/anpr-66-03-10
Daniel S Sarasin, Jason W Brady, Roy L Stevens
{"title":"Medication Safety: Reducing Anesthesia Medication Errors and Adverse Drug Events in Dentistry Part 1.","authors":"Daniel S Sarasin,&nbsp;Jason W Brady,&nbsp;Roy L Stevens","doi":"10.2344/anpr-66-03-10","DOIUrl":"https://doi.org/10.2344/anpr-66-03-10","url":null,"abstract":"<p><p>For decades, the dental profession has provided anesthesia services in office-based, ambulatory settings to alleviate pain and anxiety, ranging from local anesthesia to general anesthesia. However, despite a reported record of safety, complications occasionally occur. Two common contributing factors to general anesthesia and sedation complications are medication errors and adverse drug events. The prevention and early detection of these complications should be of paramount importance to all dental providers who administer or otherwise use anesthesia services. Unfortunately, there is a substantial lack of literature currently available regarding medication errors and adverse drug events involving anesthesia for dentistry. As a result, the profession is forced to look to the medical literature regarding these issues not only to assess the likely severity of the problem but also to develop preventive methods specific for general anesthesia and sedation as practiced within dentistry. Part 1 of this 2-part article will illuminate the problems of medication errors and adverse drug events, primarily as documented within medicine. Part 2 will focus on how these complications affect dentistry, discuss several of the methods that medicine has implemented to manage such problems, and introduce a method for addressing these issues with the dental anesthesia medication safety paradigm.</p>","PeriodicalId":94296,"journal":{"name":"Anesthesia progress","volume":"66 3","pages":"162-172"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2344/anpr-66-03-10","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信